To receive daily emails from Breaking Christian News to your inbox CLICK HERE

With a desire to inhibit metastasis, Cornell biomedical engineers have found the natural switch between the body’s inflammatory response and how malignant breast cancer cells use the bloodstream to spread.

(Ithaca, NY)—With a desire to inhibit metastasis, Cornell biomedical engineers have found the natural switch between the body’s inflammatory response and how malignant breast cancer cells use the bloodstream to spread. (PLOS ONE, Jan. 23, 2013)

Pro-inflammatory signaling molecules in blood called cytokines constitute a “switch” that induces the mechanism by which breast cancer cells “roll” and adhere to the blood vessel surface. The cancer cells eventually stick to the vessel and infiltrate it.

The laboratory of Michael R. King, Cornell professor of biomedical engineering has developed a flow chamber that mimics an inflamed endothelium (the blood vessel wall) and has used this to investigate the metastatic cascade.

In understanding the adhesive behavior of a particularly metastatic cell line, King and Yue Geng, graduate student in the field of biomedical engineering, discovered unexpectedly that these cells were unable to interact with selectins (receptor sites on the endothelium) —a key step in the metastatic cascade. This mechanism is identical to how white blood cells infiltrate blood vessels to reach the site of inflammation.

Cancer has long been associated with inflammation—the body’s natural defense mechanism—and now the researchers have demonstrated a definitive link. They found that the presence of pro-inflammatory molecules—the cytokines IL-6 and TNF-alpha—the malignant, hormone therapy-resistant breast cancer cells used in the study to adhere to the endothelial wall, leading to metastasis.

Before the cancer has spread, tumor cells first encounter IL-6 and TNF-alpha in the primary tumor’s microenvironment. These cytokines induce proliferation and aggregation of cancer cells, triggering other cancer cells to secrete more cytokines, resulting in a positive feedback loop.

The bioengineers went on to design several different cell culture setups to culture cancer cells with human plasma, IL-6 and TNF-alpha to test their hypotheses that inflammatory molecules in blood may induce adhesion capability. All of them promoted breast cancer cell metastatic behavior.

To confirm the results, the scientists used more sophisticated, real-life 3-D tumor spheroids, which are more physiologically accurate. In fact, the spheroid tumor cells exhibited the most significant increase in the interaction between the cancer cells and the blood vessel. They also treated some of the samples with a known anti-inflammatory drug called Metformin, which blocks IL-6, and they found that these samples were not able to metastasize—further accentuating their results.

Improving cancer treatment to fight metastasis via the bloodstream will depend on undoing this roll-and-stick mechanism of cancer cells, Geng says. The Cornell research could form the basis for immunotherapies to block the ligand-selectin binding of cancer cells, by first counteracting the inflammatory cytokines that, it seems, set the whole process in motion.

To receive daily emails from Breaking Christian News to your inbox CLICK HERE

'Darkness Doesn't Stand a Chance': A Great Multitude Takes Part in 2024 National Day of Prayer

City of Muenster in Texas Becomes 69th 'Safe Haven' City for the Unborn in the US

Clues: US Anti-Israel Protests Fueled by Major Foreign Funding; Backed by Iran, Hamas

Top Biden DOJ Official Busted for Lying About Past Arrest

Victory for Election Integrity: Court Blocks Undated Ballots

Trump Visits FDNY Station after Court, Buys Them Pizza. Their Response: 'Save Us, Please!'

EDUCATE Act Would Ban DEI Indoctrination in Medical Schools

DeSantis Declares Florida 'Will Not Comply' With Biden Rule Forcing 'Gender Identity' On Schools

House Bill, 'Passed With Overwhelming Support,' Would Criminalize Parts of the Bible, and Violate the Constitution

'We're Going to Light Up This World': National Day of Prayer to Lift God's Word to Combat Darkness

Trump's TIME Interview: Leftist Media is Triggered, But 'Liberty-Minded Americans' Give a Thumbs-Up

While Israel Awaits Hamas' Response to Ceasefire Deal, Bibi Says 'We Will Act' as Needed to Overcome

Parents' Rights Group Calls Out SC Librarians for Sneaking Ideologically-Charged Books into Schools

Another Boeing Whistleblower Dies; Josh Dean, 45, Succumbs to 'Sudden Illness'

CDC Concealed Evidence Linking Deaths to Pfizer and Moderna COVID-19 Vaccines, Internal Documents Reveal

AstraZeneca Finally Admits Their COVID-19 Vaccine Causes Thrombosis With Thrombocytopenia Syndrome (TTS)

Amid Anti-Israel Protests, These Fraternity Brothers Prove Patriotism Endures at US Colleges

Jailed Pro-Lifer Who Was Held in Prolonged Solitary Confinement Suffers Stroke

'The Chosen' Finds a New Home on Streaming Platform: 'A Tremendous Win for Disney's Image'

The Homeschooling Miracle in the Pacific Northwest: 'Nothing Is Impossible for God'

Steve Shultz, Managing Editor
Founder and Owner

Aimee Herd, Editor